cobicistat
Showing 1 - 22 of 22
NSCLC Trial (Cobicistat)
Not yet recruiting
- Non-small Cell Lung Cancer
- Cobicistat
- (no location specified)
Feb 17, 2023
Healthy Participants Trial in Miami (Atazanavir, Cobicistat, Atazanavir/Cobicistat Mini-tablet)
Completed
- Healthy Participants
- Atazanavir
- +2 more
-
Miami, FloridaLocal Institution - 0001
Oct 27, 2022
Healthy Participants Trial in Austin (Atazanavir/Cobicistat, Reyataz Atazanavir, Cobicistat)
Completed
- Healthy Participants
- Atazanavir/Cobicistat
- +2 more
-
Austin, TexasPPD Development, LP
Nov 18, 2021
Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Clarithromycin, Pimozide, Placebo (Part 1))
Not yet recruiting
- Drug-induced QT Prolongation
- +2 more
- Clarithromycin
- +6 more
-
West Bend, WisconsinSpaulding Clinical Research
Feb 7, 2023
Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir
Completed
- Healthy
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
- +3 more
-
Groningen, NetherlandsPRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Aug 3, 2021
Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)
Recruiting
- Acquired Immune Deficiency Syndrome (AIDS)
- HIV Infections
- ATV
- +3 more
-
Long Beach, California
- +29 more
Aug 18, 2022
Non Small Cell Lung Cancer Trial in Maastricht, Amsterdam (Cobicistat)
Completed
- Non Small Cell Lung Cancer
- Cobicistat
-
Maastricht, Limburg, Netherlands
- +1 more
Sep 23, 2022
Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)
Not yet recruiting
- Cancer Harboring BRAF Alterations
- FORE8394
- Cobicistat
- (no location specified)
Aug 15, 2022
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Hepatitis C, HIV Trial in Nijmegen (Daclatasvir, Atazanavir, Ritonavir)
Completed
- Hepatitis C
- HIV
- Daclatasvir
- +3 more
-
Nijmegen, NetherlandsCRCN, Radboud University Medical Center
Dec 4, 2020
Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir
Terminated
- Healthy
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
- +3 more
-
Groningen, NetherlandsPRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Jul 3, 2020
Infection, Human Immunodeficiency Virus, HIV Trial in Canada, United States (GSK2838232, Cobicistat)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK2838232
- Cobicistat
-
Birmingham, Alabama
- +13 more
Mar 2, 2020
Malaria Trial in Memphis (SJ733, Cobicistat)
Completed
- Malaria
- SJ733
- Cobicistat
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 28, 2018
Infection, Human Immunodeficiency Virus Trial in San Antonio (BMS-663068, Darunavir, Cobicistat)
Completed
- Infection, Human Immunodeficiency Virus
- BMS-663068
- +2 more
-
San Antonio, TexasGSK Investigational Site
Jan 22, 2018
HIV Trial run by the CC (Ritonavir, Cobicistat)
Completed
- HIV
- Ritonavir
- Cobicistat
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide fixed-dose combination (FDC),
Completed
- Healthy
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide fixed-dose combination (FDC)
- +3 more
-
Groningen, Netherlands(unnamed)
Mar 31, 2017
AIDS-related Dementia Complex Trial in Basel (Darunavir, ritonavir, cobicistat)
Terminated
- AIDS-related Dementia Complex
- Darunavir
- +2 more
-
Basel, BS, SwitzerlandDivision of Infectious Diseases, University Hospital Basel
Feb 1, 2017
Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Austin (Atazanavir, Cobicistat, Atazanavir/Cobicistat FDC)
Completed
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Atazanavir
- +2 more
-
Austin, TexasPpd Development, Inc.
Aug 19, 2014